Preventive and predictive testing
The lab platforms behind preventive health, assembled for the Asian market.
Preventive testing has moved well past ancestry novelty. Today a saliva kit, a single blood draw, or a stool sample can flag disease risk, screen for cancers before symptoms, profile your microbiome, and measure how fast you are aging. We already work with established laboratory partners on the scientific platforms behind these tests. We put them together into one integrated offering, tuned for Asian populations, that you can deliver under your own brand.
Where research becomes product
This is where we turn R&D capability into products you can sell.
Most providers offer one piece: a genotyping array, a sequencer, a single protein panel. We bring genomics and sequencing, proteomics and multiplex immunoassay, blood testing, and bioinformatics and reporting together in one connected workflow, with our established laboratory partners. That means we can assemble a complete preventive-testing menu rather than resell a single test.
You pick the categories your clients, patients or employees need. We handle the testing, check it against Asian reference data where accuracy depends on it, and return reports under your brand. You offer a preventive-health line without building a lab.
Behind many health brands
We run the DNA testing behind many businesses' health offers.
Clinics, wellness centres, pharmacies, gyms, employers and product brands put DNA testing inside what they already sell. They keep their name and their customer. We run the science with our established laboratory partners and return every report under their brand.
A supplement, skincare or nutrition range that starts from what each customer's DNA report says.
A health screening, check-up or consultation package with a DNA report inside it.
Corporate wellness, fitness, slimming and confinement programmes built around each member's own report.
Care plans from doctors, TCM and chiropractic practitioners that begin from a person's risks and medicine response.
The preventive healthcare umbrella
Preventive care, side by side with traditional care.
Traditional care begins when something is wrong. Preventive care begins earlier, while a person still feels well, by reading their own risk so they and their doctor can act sooner. The two work best together, and we build the science behind the earlier start.
| Aspect | Traditional care | Preventive care |
|---|---|---|
| Starts | When symptoms appear | Before symptoms, while a person feels well |
| Looks at | The illness in front of the doctor | A person's own risk: DNA, blood and lifestyle |
| Gives | A diagnosis and treatment | An early warning and a personal plan |
| Over time | A visit when something is wrong | A plan that is checked and updated |
Preventive testing does not replace a doctor. Every result is meant to be read with a qualified healthcare professional, who decides what to do next.
The landscape
The preventive testing market, and where we stand today.
Six categories now define direct-to-consumer and preventive testing worldwide. Each one reduces to a lab platform we already work with, so we can start you live today and build out the newer categories with you.
Genetic (DNA) wellness testing
You send a saliva kit. Our laboratory partner reads the DNA, and we return ancestry, trait, carrier, drug-response and disease-predisposition insight.
Blood biomarker panels
One blood draw, run with our laboratory partners, profiles metabolic, cardiovascular, hormonal, nutrient and inflammatory markers against optimal ranges for proactive health.
Multiplex protein screening
Multiplex panels quantify tens to thousands of plasma proteins at once, from microlitre volumes, for risk stratification and disease-signature work.
Microbiome testing
Our laboratory partner sequences the gut, oral or skin microbial community, and we turn it into diet, digestive and wellness insight, referenced to Asian baselines.
Multi-cancer early detection
A blood draw reads tumour-shed cell-free DNA to look for a shared cancer signal across many cancer types, before symptoms appear.
Biological age & multi-omics
Our laboratory partners measure DNA methylation, and we combine it with genomics, protein, microbiome and metabolic data to track pace of aging over time.
Live today, Building and On the roadmap describe our current delivery stage per category. Ask us where any specific test stands before you plan a launch around it.
One group, four platforms
Preventive testing runs on a small set of platforms. We bring all of them together.
Every category above reduces to these four. That is why you can start with DNA wellness today and extend the same relationship into blood, microbiome, protein screening and biological age without ever changing supplier.
Genomics and sequencing
Genotyping arrays and next-generation sequencing power DNA wellness, microbiome (16S and shotgun), methylation-based biological-age clocks, and the cell-free DNA pipelines behind multi-cancer early detection.
Proteomics & multiplex immunoassay (PrimePlex)
Runs multiplex protein panels, quantifying many analytes from a small blood volume for biomarker and risk-signature work, and supports the protein components of advanced blood-based screening.
Clinical lab partners
Our laboratory partners' chemistry and immunoassay analysers deliver the comprehensive metabolic, lipid, hormonal, nutrient and inflammatory panels that anchor proactive health screening.
Bioinformatics and reporting
Turns raw genotyping, sequencing and biomarker data into scored, plain-language reports, applies cross-ancestry methods and Asian reference data, and produces the branded output your clinician or member reads.
Laboratory standards
Our DNA tests are run with our laboratory partner. These are its certifications.
What each certification covers
- ISO 9001:2015 · Quality management
- BSI certifies the laboratory's quality system for its microarray (DNA chip) and sequencing services. Valid to Oct 2028.
- CAP accreditation · Clinical laboratory
- Accredits two of the laboratory's sites for clinical sequencing (NGS) tests. Accredited to Mar 2028.
- CLIA certificate · Clinical laboratory
- US federal certificate that lets two of the laboratory's sites test human samples. Valid to Jan 2027 and Jul 2028.
- Illumina Propel certified · Platform
- Illumina certifies the laboratory to run its Infinium microarrays and HiSeq sequencers. No end date.
- ISMS-P · Data protection
- A national government certificate for protecting personal data and information, covering the laboratory's sequencing and diagnostics services. Valid to Mar 2027.
Certificates checked 17 Sep 2026.
A sample report
We translate the data into something a person can act on.
Whatever the test, the deliverable is the same: a colour-coded, plain-language report that a member and their clinician can read and use, weighted for Asian populations.
Report menu
Insight across the topics that matter.
Academia and industry
The bridge between universities and industry.
Research teams find out what a marker means. Businesses put that knowledge in front of people. Prima Nexus stands between the two, so good science reaches the market, and what the market learns flows back to research.
Universities and research institutes
- Research teams at more than 40 institutions have worked with us since 2014.
- The programmes we support have contributed to more than 150 papers in peer-reviewed journals.
Prima Nexus, the bridge
- Turns research-grade science into tests that businesses can offer.
- Gives back to research: the free Malaysian Cohort Browser, the Biomarker Research Fund, and hands-on workshops such as Variant to Verdict with UKM.
Businesses and health providers
- Clinics, hospitals, wellness centres, pharmacies, gyms and employers offer preventive testing under their own brand.
- Every report they give rests on the same published science researchers use.
We follow Malaysia's national genomics effort too: Prima Nexus was invited to the launch of MyGenom, the national genome programme.
Ancestry and population genomics
A growing genetic map of Southeast Asia.
Southeast Asia is home to hundreds of peoples, yet most genetic references were built from other populations. Our ancestry reports show how a person's DNA connects to the peoples of the region. Our own Malaysian Reference Cohort, built since 2019 from our testing and from community participation, grows every month, and reports in four languages let partners across the region offer them in their customers' own language.
Malay
Chinese
Indian
Javanese
Filipino
Vietnamese
Lao
Khmer
Why Prima Nexus
Why partners build their preventive line with us.
Built for Asian populations
Most risk models and reference ranges were trained on European-ancestry data, and their accuracy drops in Asian populations. We weight interpretation toward Asian and Southeast Asian populations, so the insight you deliver fits the people in front of you.
See it in our own Malaysian data: the Malaysian Cohort Browser, the Malaysian Reference Cohort, and why one Malaysian number describes nobody.
The whole stack, one supplier
We bring genomics, proteomics and multiplex immunoassay, blood testing and bioinformatics together with our established laboratory partners, and you deal only with us. Launch DNA wellness now and add blood panels, microbiome, protein screening or biological age later, without onboarding a new lab each time.
White-label by default
Reports carry your brand, not ours. Clinics, wellness and screening centres, pharmacies, gyms, employers, hospitals and public-health programmes present an integrated preventive-testing line as their own.
No licence fees, pay per activation
You do not carry the cost of building or licensing a lab. You pay when a kit is activated, so the offering scales with your demand instead of your capital.
Non-invasive and multilingual
Self-collected samples, roughly 14 to 18 day turnaround, and reports in four languages weighted for Asian populations, built to fit the way clinics, centres and workplaces already work.
Product-ready, from our R&D
We commercialise research-grade capability into market-ready tests. You get a finished product to offer, not a science project to finish.
Who we serve
A managed service for the organisations that guide health.
Delivered as a white-label capability, so partners can offer preventive testing under their own brand, with no licence fees and no equipment to buy.
Genomic and preventive-testing results indicate risk and predisposition. They are not a diagnosis and do not confirm or rule out disease. They are intended to support proactive health decisions alongside a qualified healthcare professional, and never to replace clinical assessment, diagnosis or treatment.
In the news
Genomics and preventive testing in the news
Prima Nexus Collaborates With UKM's CORE on Hands-On Bioinformatics Workshop for Medical Genetics
“Bioinformatics for Medical Genetics: From Variant to Verdict” teaches researchers how to detect, annotate, prioritise and interpret genomic variants.
Read the story →
Prima Nexus Managing Partner Invited to National Workshop on Malaysia's Precision Medicine Strategic Plan
The Ministry of Health and MOSTI brought industry leaders, scientists and innovators together to help shape how precision medicine will be planned and delivered in Malaysia.
Read the story →
Prima Nexus Invited to the Launch of MyGenom, Malaysia's National Genome Programme
The Ministry of Health and MOSTI launched MyGenom at the National Institutes of Health in Setia Alam, to sequence Malaysian genomes and build the country's own genetic reference.
Read the story →Partner with Prima Nexus
Offer preventive testing under your own brand.
Tell us who you serve (patients, clients, members, employees or a population-health programme) and which categories you want to lead with. We map them to our platforms and return a white-label offering you can put your name on.